+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bone lead and the diagnosis of lead nephropathy

Bone lead and the diagnosis of lead nephropathy

Contributions to Nephrology 64: 102-108

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 039415094

Download citation: RISBibTeXText

PMID: 3141113

Related references

Interrelationships of urinary lead after DMSA challenge, bone lead burden, and blood lead in lead exposed workers. Veterinary and Human Toxicology 36(4): 363, 1994

Bone lead, hypertension, and lead nephropathy. Environmental Health Perspectives 78: 57-60, 1988

Study of the relationships between bone lead levels and its variation with time and the cumulative blood lead index, in a repeated bone lead survey. Journal of Environmental Monitoring 2(3): 271-276, 2000

Comparison of lead bioavailability in F344 rats fed lead acetate, lead oxide, lead sulfide, or lead ore concentrate from Skagway, Alaska. Journal of Toxicology and Environmental Health 39(1): 79-93, 1993

Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environmental Health Perspectives 115(3): 483-492, 2007

Lead in bone II: skeletal-lead content as an indicator of lifetime lead ingestion and the social correlates in an archaeological population. American Journal of Physical Anthropology 55(3): 285-291, 1981

Past occupational exposure to lead: association between current blood lead and bone lead. Archives of Environmental and Occupational Health 62(4): 183-186, 2007

Melatonin reduces lead levels in blood, brain and bone and increases lead excretion in rats subjected to subacute lead treatment. Toxicology Letters 233(2): 78-83, 2015

Clinical applications of L-line X-ray fluorescence to estimate bone lead values in lead-poisoned young children and in children, teenagers, and adults from lead-exposed and non-lead-exposed suburban communities in the United States. Toxicology and Industrial Health 13(2-3): 211-218, 1997

Case of optic atrophy due to lead with late manifestations; importance of the mobilization of lead in the clinical diagnosis of lead poisoning. La Medicina del Lavoro 42(5): 187-191, 1951

Significance of lead and porphyrine determination in blood and urine of population in areas of lead production and manufacture for differential diagnosis and expert testimony of lead injurious effects and poisoning. Wiener Zeitschrift für Innere Medizin und ihre Grenzgebiete 39(7): 274-285, 1958

Serum (plasma) lead, blood lead, and bone lead. American Journal of Industrial Medicine 32(3): 319-320, 1997

Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney International 41(5): 1192-1203, 1992

Experimental model of lead nephropathy. III. Continuous low-level lead administration. Archives of Environmental Health 48(4): 271-278, 1993